OCULAR THERAPEUTIX, INC Selling and Marketing Expense
OCULAR THERAPEUTIX, INC (OCUL) reported Selling and Marketing Expense of $17.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-03
- OCULAR THERAPEUTIX, INC selling and marketing expense for the quarter ending 2026-06-30 was $17.28M, a 25.84% increase year-over-year.
- OCULAR THERAPEUTIX, INC selling and marketing expense for the quarter ending 2026-03-31 was $16.58M, a 17.17% increase year-over-year.
- OCULAR THERAPEUTIX, INC selling and marketing expense for the quarter ending 2025-12-31 was $12.96M, a 19.53% increase year-over-year.
- OCULAR THERAPEUTIX, INC selling and marketing expense for the quarter ending 2025-09-30 was $13.09M, a 23.79% increase year-over-year.
- OCULAR THERAPEUTIX, INC selling and marketing expense for fiscal 2025 was $53.92M, a 29.65% increase from fiscal 2024.
- OCULAR THERAPEUTIX, INC selling and marketing expense for fiscal 2024 was $41.59M, a 2.57% increase from fiscal 2023.
- OCULAR THERAPEUTIX, INC selling and marketing expense for fiscal 2023 was $40.55M, a 1.57% increase from fiscal 2022.
- OCULAR THERAPEUTIX, INC selling and marketing expense for fiscal 2022 was $39.92M, a 13.45% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.28M 10-Q · filed 2026-08-03 | $33.85M 10-Q · filed 2026-08-03 | $46.81M derived: sum of 3 quarters · filed 2026-08-03 | $59.90M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $16.58M 10-Q · filed 2026-05-05 | $29.53M derived: sum of 2 quarters · filed 2026-05-05 | $42.62M derived: sum of 3 quarters · filed 2026-05-05 | $56.35M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $12.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $26.05M derived: sum of 2 quarters · filed 2026-02-05 | $39.77M derived: sum of 3 quarters · filed 2026-08-03 | $53.92M 10-K · filed 2026-02-05 |
| 2025-09-30 | $13.09M 10-Q · filed 2025-11-04 | $26.82M derived: sum of 2 quarters · filed 2026-08-03 | $40.97M 10-Q · filed 2025-11-04 | $51.80M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $13.73M 10-Q · filed 2026-08-03 | $27.88M 10-Q · filed 2026-08-03 | $38.72M derived: sum of 3 quarters · filed 2026-08-03 | $49.29M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $14.15M 10-Q · filed 2026-05-05 | $24.99M derived: sum of 2 quarters · filed 2026-05-05 | $35.56M derived: sum of 3 quarters · filed 2026-05-05 | $45.55M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $21.41M derived: sum of 2 quarters · filed 2026-02-05 | $31.41M derived: sum of 3 quarters · filed 2026-02-05 | $41.59M 10-K · filed 2026-02-05 |
| 2024-09-30 | $10.57M 10-Q · filed 2025-11-04 | $20.57M derived: sum of 2 quarters · filed 2025-11-04 | $30.75M 10-Q · filed 2025-11-04 | $39.99M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-06-30 | $9.99M 10-Q · filed 2025-08-05 | $20.18M 10-Q · filed 2025-08-05 | $29.42M derived: sum of 3 quarters · filed 2026-02-05 | $38.74M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-03-31 | $10.18M 10-Q · filed 2025-05-05 | $19.43M derived: sum of 2 quarters · filed 2026-02-05 | $28.74M derived: sum of 3 quarters · filed 2026-02-05 | $39.90M derived: sum of 4 quarters · filed 2026-02-05 |
| 2023-12-31 | $9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $18.56M derived: sum of 2 quarters · filed 2026-02-05 | $29.71M derived: sum of 3 quarters · filed 2026-02-05 | $40.55M 10-K · filed 2026-02-05 |
| 2023-09-30 | $9.31M 10-Q · filed 2024-11-14 | $20.47M derived: sum of 2 quarters · filed 2024-11-14 | $31.30M 10-Q · filed 2024-11-14 | $41.84M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $11.15M 10-Q · filed 2024-08-07 | $21.99M 10-Q · filed 2024-08-07 | $32.52M derived: sum of 3 quarters · filed 2025-03-03 | $42.71M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $10.84M 10-Q · filed 2024-05-07 | $21.37M derived: sum of 2 quarters · filed 2025-03-03 | $31.55M derived: sum of 3 quarters · filed 2025-03-03 | $41.69M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $10.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $20.72M derived: sum of 2 quarters · filed 2025-03-03 | $30.86M derived: sum of 3 quarters · filed 2025-03-03 | $39.92M 10-K · filed 2025-03-03 |
| 2022-09-30 | $10.19M 10-Q · filed 2023-11-07 | $20.33M derived: sum of 2 quarters · filed 2023-11-07 | $29.39M 10-Q · filed 2023-11-07 | $38.52M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $10.14M 10-Q · filed 2023-08-07 | $19.20M 10-Q · filed 2023-08-07 | $28.34M derived: sum of 3 quarters · filed 2024-03-11 | $37.91M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | $9.06M 10-Q · filed 2023-05-08 | $18.20M derived: sum of 2 quarters · filed 2024-03-11 | $27.77M derived: sum of 3 quarters · filed 2024-03-11 | $36.17M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $18.71M derived: sum of 2 quarters · filed 2024-03-11 | $27.10M derived: sum of 3 quarters · filed 2024-03-11 | $35.19M 10-K · filed 2024-03-11 |
| 2021-09-30 | $9.58M 10-Q · filed 2022-11-07 | $17.97M derived: sum of 2 quarters · filed 2022-11-07 | $26.05M 10-Q · filed 2022-11-07 | $32.86M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $8.39M 10-Q · filed 2022-08-08 | $16.48M 10-Q · filed 2022-08-08 | $23.29M derived: sum of 3 quarters · filed 2023-03-06 | $29.81M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $8.09M 10-Q · filed 2022-05-09 | $14.90M derived: sum of 2 quarters · filed 2023-03-06 | $21.42M derived: sum of 3 quarters · filed 2023-03-06 | $27.57M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $13.33M derived: sum of 2 quarters · filed 2023-03-06 | $19.48M derived: sum of 3 quarters · filed 2023-03-06 | $26.61M 10-K · filed 2023-03-06 |
| 2020-09-30 | $6.52M 10-Q · filed 2021-11-08 | $12.67M derived: sum of 2 quarters · filed 2021-11-08 | $19.80M 10-Q · filed 2021-11-08 | $26.95M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $6.15M 10-Q · filed 2021-08-09 | $13.28M 10-Q · filed 2021-08-09 | $20.43M derived: sum of 3 quarters · filed 2022-02-28 | $27.20M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $7.13M 10-Q · filed 2021-05-05 | $14.27M derived: sum of 2 quarters · filed 2022-02-28 | $21.05M derived: sum of 3 quarters · filed 2022-02-28 | $28.27M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $13.92M derived: sum of 2 quarters · filed 2022-02-28 | $21.14M derived: sum of 3 quarters · filed 2022-02-28 | $24.49M 10-K · filed 2022-02-28 |
| 2019-09-30 | $6.78M 10-Q · filed 2020-11-05 | $14.00M derived: sum of 2 quarters · filed 2020-11-05 | $17.35M 10-Q · filed 2020-11-05 | $19.64M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $7.22M 10-Q · filed 2020-08-07 | $10.57M 10-Q · filed 2020-08-07 | $12.86M derived: sum of 3 quarters · filed 2020-08-07 | $13.93M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $3.35M 10-Q · filed 2020-05-08 | $5.64M derived: sum of 2 quarters · filed 2020-05-08 | $6.71M derived: sum of 3 quarters · filed 2020-05-08 | $7.57M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $3.36M derived: sum of 2 quarters · filed 2020-03-12 | $4.22M derived: sum of 3 quarters · filed 2020-03-12 | $4.94M 10-K · filed 2020-03-12 |
| 2018-09-30 | $1.07M 10-Q · filed 2019-11-12 | $1.93M derived: sum of 2 quarters · filed 2019-11-12 | $2.65M 10-Q · filed 2019-11-12 | $3.55M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $867.00K 10-Q · filed 2019-08-07 | $1.58M 10-Q · filed 2019-08-07 | $2.49M derived: sum of 3 quarters · filed 2020-03-12 | $5.72M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $717.00K 10-Q · filed 2019-05-10 | $1.62M derived: sum of 2 quarters · filed 2020-03-12 | $4.86M derived: sum of 3 quarters · filed 2020-03-12 | $11.69M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $4.14M derived: sum of 2 quarters · filed 2020-03-12 | $10.97M derived: sum of 3 quarters · filed 2020-03-12 | $17.00M 10-K · filed 2020-03-12 |
| 2017-09-30 | $3.24M 10-Q · filed 2018-11-07 | $10.07M derived: sum of 2 quarters · filed 2018-11-07 | $16.10M 10-Q · filed 2018-11-07 | $18.62M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $6.83M 10-Q · filed 2018-08-07 | $12.86M 10-Q · filed 2018-08-07 | $15.38M derived: sum of 3 quarters · filed 2019-03-07 | $16.68M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $6.03M 10-Q · filed 2018-05-08 | $8.55M derived: sum of 2 quarters · filed 2019-03-07 | $9.85M derived: sum of 3 quarters · filed 2019-03-07 | $11.34M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $3.82M derived: sum of 2 quarters · filed 2019-03-07 | $5.31M derived: sum of 3 quarters · filed 2019-03-07 | $6.70M 10-K · filed 2019-03-07 |
| 2016-09-30 | $1.29M 10-Q · filed 2017-11-07 | $2.79M derived: sum of 2 quarters · filed 2017-11-07 | $4.17M 10-Q · filed 2017-11-07 | $5.32M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $1.49M 10-Q · filed 2016-08-09 | $2.88M 10-Q · filed 2017-08-08 | $4.02M derived: sum of 3 quarters · filed 2018-03-08 | $4.82M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $1.39M 10-Q · filed 2017-05-05 | $2.53M derived: sum of 2 quarters · filed 2018-03-08 | $3.33M derived: sum of 3 quarters · filed 2018-03-08 | $4.37M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.94M derived: sum of 2 quarters · filed 2018-03-08 | $2.98M derived: sum of 3 quarters · filed 2018-03-08 | $3.85M 10-K · filed 2018-03-08 |
| 2015-09-30 | $798.00K 10-Q · filed 2016-11-09 | $1.84M derived: sum of 2 quarters · filed 2016-11-09 | $2.71M 10-Q · filed 2016-11-09 | $3.37M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $1.04M 10-Q · filed 2016-08-09 | $1.91M 10-Q · filed 2016-08-09 | $2.57M derived: sum of 3 quarters · filed 2017-03-10 | $3.05M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $870.00K 10-Q · filed 2016-05-10 | $1.53M derived: sum of 2 quarters · filed 2017-03-10 | $2.01M derived: sum of 3 quarters · filed 2017-03-10 | $2.54M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | $658.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $1.14M derived: sum of 2 quarters · filed 2017-03-10 | $1.67M derived: sum of 3 quarters · filed 2017-03-10 | $1.98M 10-K · filed 2017-03-10 |
| 2014-09-30 | $479.00K 10-Q · filed 2015-11-10 | $1.01M derived: sum of 2 quarters · filed 2015-11-10 | $1.32M 10-Q · filed 2015-11-10 | $1.52M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $535.00K 10-Q · filed 2015-08-10 | $845.00K 10-Q · filed 2015-08-10 | $1.04M derived: sum of 3 quarters · filed 2016-03-10 | $1.19M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $310.00K 10-Q · filed 2015-05-15 | $507.00K derived: sum of 2 quarters · filed 2016-03-10 | $655.00K derived: sum of 3 quarters · filed 2016-03-10 | $798.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $345.00K derived: sum of 2 quarters · filed 2016-03-10 | $488.00K derived: sum of 3 quarters · filed 2016-03-10 | $625.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | $148.00K 10-Q · filed 2014-11-12 | $291.00K derived: sum of 2 quarters · filed 2014-11-12 | $428.00K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $143.00K 10-Q · filed 2014-08-29 | $280.00K 10-Q · filed 2014-08-29 | ||
| 2012-12-31 | $657.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |